Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of early kidney allograft rejection: influencing factors in metabolite-based urine analysis.

Frontiers in medicine·2026
Same author

Role of B vitamins in modulating homocysteine and metabolic pathways linked to brain atrophy: Metabolomics insights from the VITACOG trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Nuclear magnetic resonance-based lipid metabolite profiles for differentiation of patients with liver cirrhosis with and without hepatocellular carcinoma.

Journal of cancer research and clinical oncology·2025
Same author

Correction: Stämmler et al. Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C. <i>Diagnostics</i> 2021, <i>11</i>, 2291.

Diagnostics (Basel, Switzerland)·2024
Same author

Performance of Nuclear Magnetic Resonance-Based Estimated Glomerular Filtration Rate in a Real-World Setting.

Bioengineering (Basel, Switzerland)·2023
Same author

Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease.

BMC nephrology·2023

Related Experiment Video

Updated: Jul 13, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Biomarkers for prostate cancer.

Eric Schiffer1

  • 1Mosaiques Diagnostics and Therapeutics AG, Mellendorfer Str. 7-9, 30625 Hannover, Germany. schiffer@mosaiques-diagnostics.com

World Journal of Urology
|August 11, 2007
PubMed
Summary

Novel prostate cancer (PCa) biomarkers are under investigation for diagnostic use. While many candidates show promise, further validation is needed for prognostic tools and treatment strategies.

Area of Science:

  • Urology
  • Oncology
  • Biomarker Discovery

Background:

  • Prostate cancer (PCa) diagnosis urgently requires novel, reliable biomarkers.
  • Current diagnostic methods have limitations, necessitating advanced detection strategies.

Purpose of the Study:

  • To review current findings impacting prostate cancer research and biomarker utility.
  • To assess the potential of novel biomarkers for PCa diagnosis and management.

Main Methods:

  • Review of enzyme-linked immunosorbent assays (ELISA) for single biomarkers.
  • Analysis of quantitative polymerase chain reaction (PCR)-based assays for DNA/RNA markers.
  • Evaluation of high-throughput proteomic profiling of PCa specimens.

Main Results:

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Experiment Videos

Last Updated: Jul 13, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

  • Multiple promising biomarker candidates have been identified.
  • Various sample sources (tissue, blood, urine, seminal plasma) present distinct advantages and disadvantages.
  • Most identified markers require further extensive validation.

Conclusions:

  • Identified biomarkers hold potential for novel prognostic tools in prostate cancer.
  • These markers may offer new insights into PCa pathophysiology.
  • Further research could lead to improved PCa treatment strategies.